MitraClip®植入术与左心耳封堵术联合应用的初步结果
Initial Results of Combined MitraClip® Implantation and Left Atrial Appendage Occlusion.
作者信息
Freixa Xavier, Estévez-Loureiro Rodrigo, Carrasco-Chinchilla Fernando, Arzamendi Dabit, Jiménez-Quevedo Pilar, Nombela-Franco Luis, Cruz-González Ignacio, Amat-Santos Ignacio J, Sabaté Manel
机构信息
Department of Cardiology, Hospital Clinic of Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain. Electronic correspondence:
Department of Cardiology, Complejo Asistencial Universitario de Leon, Spain.
出版信息
J Heart Valve Dis. 2017 Mar;26(2):169-174.
BACKGROUND
Atrial fibrillation is present in 30-50% of patients undergoing percutaneous mitral valve repair. The presence of a formal contraindication to oral anticoagulation is also very common in these patients. In this context, percutaneous left atrial appendage occlusion (LAAO) may be a valid alternative for these patients. The study aim was to assess the feasibility, safety, and technical considerations of the combination of percutaneous mitral valve repair using the MitraClip system and LAAO. The present study describes the multicenter experience of combined MitraClip and LAAO procedures.
METHODS
Between April 2012 and April 2016, six patients were successfully treated with the combined procedure.
RESULTS
In all patients, mitral valve repair was performed before LAAO. Both procedures were successfully performed in all cases without any relevant procedural complication or mortality.
CONCLUSIONS
According to the results of the present study, a combination of both techniques appears to be feasible and safe, with favorable in-hospital outcomes.
背景
在接受经皮二尖瓣修复术的患者中，30%至50%存在心房颤动。这些患者中存在口服抗凝药的正式禁忌证也很常见。在此背景下，经皮左心耳封堵术（LAAO）可能是这些患者的有效替代方案。本研究的目的是评估使用MitraClip系统进行经皮二尖瓣修复术与LAAO联合应用的可行性、安全性和技术要点。本研究描述了MitraClip和LAAO联合手术的多中心经验。
方法
2012年4月至2016年4月期间，6例患者成功接受了联合手术。
结果
所有患者均在LAAO之前进行了二尖瓣修复。所有病例中两种手术均成功完成，无任何相关手术并发症或死亡。
结论
根据本研究结果，两种技术联合应用似乎可行且安全，住院结局良好。
Zotero 插件